Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

(2010) J Bernhard et al.   BRITISH JOURNAL OF CANCER

Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer

(2010) R. Girelli et al.   BRITISH JOURNAL OF SURGERY

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

(2010) Hedy Lee Kindler et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

(2010) Philip A. Philip et al.   JOURNAL OF CLINICAL ONCOLOGY

Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer

(2010) Soley Bayraktar   WORLD JOURNAL OF GASTROENTEROLOGY

Radiofrequency ablation of locally advanced pancreatic adenocarcinoma: An overview

(2010) Mirko D’Onofrio   WORLD JOURNAL OF GASTROENTEROLOGY

Changing the Paradigm in Conducting Randomized Clinical Studies in Advanced Pancreatic Cancer: An Opportunity for Better Clinical Development

(2009) Josep Tabernero et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer

(2009) Eric Van Cutsem et al.   JOURNAL OF CLINICAL ONCOLOGY

Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment

(2009) Philip A. Philip et al.   JOURNAL OF CLINICAL ONCOLOGY